Prednisone for acute virus-associated wheeze in children: Panacea or one more brick in the wall?
In 2007, the Joint Commission created a national standard on the inpatient care of children admitted to the hospital for asthma that included a course of systemic corticosteroids as a quality indicator.10 This issue of the Journal of Allergy and Clinical Immunology includes the first placebo-control...
Gespeichert in:
Veröffentlicht in: | Journal of allergy and clinical immunology 2015-03, Vol.135 (3), p.699-700 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | In 2007, the Joint Commission created a national standard on the inpatient care of children admitted to the hospital for asthma that included a course of systemic corticosteroids as a quality indicator.10 This issue of the Journal of Allergy and Clinical Immunology includes the first placebo-controlled randomized clinical trial conducted by Jartti et al11 to address the effectiveness of prednisolone treatment for the first acute wheeze episode in young children infected with human rhinovirus. |
---|---|
ISSN: | 0091-6749 1097-6825 |
DOI: | 10.1016/j.jaci.2014.10.056 |